RED BANK, NJ / ACCESS Newswire / July 23, 2025 / Tharimmune, Inc. (the “Company” and “Tharimmune”) (Nasdaq Capital ...

Celcuity Inc. (Nasdaq: CELC) (the 'Company”), a clinical-stage biotechnology company pursuing development of targeted ...

Justin Sun's Tron Inc. filed a S-3 form with the Securities and Exchange Commission (SEC) on July 28, requesting to issue up ...

AST SpaceMobile is raising capital through a private offering of convertible notes and a direct offering of common stock, which may lead to some stock dilution. The company recently formed a joint ...

On June 5, Bitmine stock began trading on the New York Stock Exchange with little fanfare, closing at $7.75 per share.

Dana Incorporated (NYSE: DAN) announced today that its board of directors has declared a dividend on its common stock.

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or ...

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ('Qualigen' or the 'Company'), a life sciences company focused on developing ...

Velo3D, Inc. (OTC: VLDX), a leading provider of additive manufacturing technologies for mission-critical metal parts ...

Bank of America's board has authorized a $40 billion common stock repurchase program. The bank said Wednesday the buyback is effective Aug. 1, and will replace its current program that expires that ...

ASP Isotopes (ASPI) has priced an offering of 7.5 million shares of its common stock at $8.00 per share, raising approximately $60 million in gross proceeds.

Stephens Inc., Keefe, Bruyette & Woods, A Stifel Company and Morgan Stanley are acting as joint book-running managers for the offering. Raymond James & Associates, Inc. and Robert W. Baird & Co.